Fulcrum Therapeutics, Inc. · NASDAQ:FULC
BlackRock, Inc. reported a 6.00% stake in Fulcrum Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 17, 2025
BlackRock, Inc. reported a 6.00% stake in Fulcrum Therapeutics, Inc., 3,270,322 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G/A).
- Stake
- 6.00%
- Shares
- 3,270,322
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.00% | 3,270,322 |
Source
Related
- Fulcrum Therapeutics, Inc.
- BlackRock, Inc.
- Fulcrum Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 17, 2025
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026